Lepu Biopharma Co., Ltd. (HKG:2157)

Lepu Biopharma Statistics

Total Valuation

Lepu Biopharma has a market cap or net worth of HKD 15.25 billion. The enterprise value is 15.63 billion.

Market Cap	15.25B
Enterprise Value	15.63B

Important Dates

The last earnings date was Thursday, August 21, 2025.

Earnings Date	Aug 21, 2025
Ex-Dividend Date	n/a

Share Statistics

Lepu Biopharma has 1.80 billion shares outstanding. The number of shares has increased by 2.76% in one year.

Current Share Class	1.80B
Shares Outstanding	1.80B
Shares Change (YoY)	+2.76%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	33.45%
Owned by Institutions (%)	8.12%
Float	854.41M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	19.87
PB Ratio	19.55
P/TBV Ratio	49.22
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-80.49
EV / Sales	20.36
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.63, with a Debt / Equity ratio of 1.29.

Current Ratio	0.63
Quick Ratio	0.59
Debt / Equity	1.29
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5.41

Financial Efficiency

Return on equity (ROE) is -24.53% and return on invested capital (ROIC) is -5.75%.

Return on Equity (ROE)	-24.53%
Return on Assets (ROA)	-3.96%
Return on Invested Capital (ROIC)	-5.75%
Return on Capital Employed (ROCE)	-12.16%
Revenue Per Employee	1.41M
Profits Per Employee	-355,629
Employee Count	498
Asset Turnover	0.29
Inventory Turnover	2.35

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +208.39% in the last 52 weeks. The beta is -0.14, so Lepu Biopharma's price volatility has been lower than the market average.

Beta (5Y)	-0.14
52-Week Price Change	+208.39%
50-Day Moving Average	7.92
200-Day Moving Average	4.72
Relative Strength Index (RSI)	48.00
Average Volume (20 Days)	25,792,843

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Lepu Biopharma had revenue of HKD 767.54 million and -194.17 million in losses. Loss per share was -0.11.

Revenue	767.54M
Gross Profit	678.58M
Operating Income	-166.56M
Pretax Income	-216.88M
Net Income	-194.17M
EBITDA	-73.77M
EBIT	-166.56M
Loss Per Share	-0.11

Balance Sheet

The company has 587.71 million in cash and 1.01 billion in debt, giving a net cash position of -418.01 million or -0.23 per share.

Cash & Cash Equivalents	587.71M
Total Debt	1.01B
Net Cash	-418.01M
Net Cash Per Share	-0.23
Equity (Book Value)	779.97M
Book Value Per Share	0.48
Working Capital	-446.36M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 88.41%, with operating and profit margins of -21.70% and -25.30%.

Gross Margin	88.41%
Operating Margin	-21.70%
Pretax Margin	-28.26%
Profit Margin	-25.30%
EBITDA Margin	-9.61%
EBIT Margin	-21.70%
FCF Margin	n/a

Dividends & Yields

Lepu Biopharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.76%
Shareholder Yield	n/a
Earnings Yield	-1.27%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Lepu Biopharma has an Altman Z-Score of 0.24 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.24
Piotroski F-Score	2